Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025
Market Cap 1 91.84
Change -
Enterprise Value (EV) 1 61.1
Change -
P/E 21.2x
PBR 1.04x
PEG -1.1x
Capitalization / Revenue 1.12x
EV / Revenue 0.74x
EV / EBITDA 7.34x
EV / EBIT 16x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 1.896
Distribution rate -
Net sales 1 82.35
EBITDA 1 8.319
EBIT 1 3.821
Net income 1 3.947
Net Debt 1 -30.75
Reference price 2 40.24
Nbr of stocks (in thousands) 2,282
Announcement Date 8/26/25
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 960K
-165.22x13.72x-186.74x-.--% 39.41B
22.99x2.06x12.1x0.93% 25.27B
18.01x1.38x7.83x4.86% 7.68B
354.97x - - - 5.44B
50.79x9.39x32.36x0.98% 3.32B
-22.16x - - - 2.11B
-54.99x - - -.--% 2.09B
33.72x1.69x12.9x1.52% 1.9B
28.21x1.09x8.62x0.88% 1.66B
Average 29.59x 4.89x -18.82x 1.31% 8.89B
Weighted average by Cap. -42.11x 8.07x -86.42x 0.84%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited